Indaptus Therapeutics, Inc. logo

Indaptus Therapeutics, Inc.

INDP • NASDAQ

Indaptus Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Junyi Dai, with a market cap of $4.1M.

Market Cap$4.1M
Employees7.0
CEOJunyi Dai
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Income StatementBalance SheetCash FlowBusiness Segments

Financials

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
IND

Indaptus Therapeutics, Inc. FAQ

Common questions about Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.

Indaptus Therapeutics, Inc. has approximately 7 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Indaptus Therapeutics, Inc. (INDP) Q1 2026 Earnings - OpenCapital